mine in the mesolimbic pathway, a defective dop- amine function in the mesocortical pathway may contribute to the development of negative symptoms (Weinberger & Berman, 1988). Further, it has been proposed that negative symptoms represent a conse- quence of impaired frontal lobe function (Berge et al., 2011; Frith